Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2025

Suppliers with verified business licenses

Registered Capital
1000000 RMB
Plant Area
101~500 square meters
  • Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
  • Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
  • Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
  • Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
  • Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
  • Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
QS-Dolutegravir
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>99%
Product Name
Dolutegravir
Name
Dolutegravir Powder
Appearance
White Powder
Colour
White
Grade
Pharmaceutical Grade
Assay
>99%
Application
API
Specific
COA
Test Method
HPLC
MW
419.38
Mf
C20h19f2n3o5
CAS
1051375-16-6
Density
1.53
Melting Point
190-193c
Boiling Point
760 Mmhg
Transport Package
Negotiable
Specification
>99%
Trademark
QS-Dolutegravir
Origin
Xian
Production Capacity
10000kg/Month

Product Description

Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
Product Description
Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
 
Product Details
Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
Product Name Dolutegravir
Appearance White Powder
Assay 99%
MW 419.38
MF C20H19F2N3O5
Dolutegravir is an antiretroviral drug used to treat human immunodeficiency virus (HIV) infection.
Dolutegravir is an HIV integrase inhibitor, which interferes with the relevant enzymes required for HIV reproduction. It is taken once a day. The drug is applicable to adults infected with HIV who have not taken HIV antiretroviral therapy drugs, and adults infected with HIV who have previously received other HIV integrase inhibitors. Clinical doctors can order Dolutegravir or other antiretroviral drugs for children aged 12 years or older and weighing at least 40 kilograms. These patients are in the early stages of treatment or in the midst of treatment and have not previously used any other HIV integrase inhibitors. People living with HIV need personalized treatment programmes to meet their situation and their needs.
Application&Function
Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirMechanism of Action
The main mechanism of action of Dolutegravir is by inhibiting the activity of HIV integrase. Integrating enzymes are key enzymes in the HIV lifecycle, responsible for integrating the virus's genetic material into the host cell's DNA, thereby promoting virus replication. Dolutegravir effectively inhibits virus replication by binding to integrase, preventing the binding of viral DNA to host DNA.
Drug efficacy
Dolutegravir is very effective in the treatment of AIDS. Clinical studies have shown that patients treated with this drug can rapidly reduce their HIV viral load to undetectable levels. Due to its good tolerance, many patients can achieve long-term viral suppression when receiving Dolutegravir treatment, which is of great significance for improving patients' quality of life and prolonging their lives.
Drug interactions
Dolutegravir may interact with other drugs when used simultaneously. For example, enzyme inducers may increase the activity of CYP3A4 enzyme, thereby reducing the plasma concentration of Dolutegravir; Enzyme inhibitors may lead to an increase in plasma concentration of Dolutegravir. Therefore, when patients use Dolutegravir and other medications simultaneously, it may be necessary to adjust the dosage to ensure its efficacy and safety.
Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir
 
Specification
Factory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical DolutegravirFactory Supply CAS 1051375-16-6 Dolutegravir Sodium Pharmaceutical Dolutegravir

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier